• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YKL-40 和神经元特异性烯醇化酶在神经退行性变和神经炎症中的作用。

YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation.

机构信息

Department of Medical Biology, Medical University-Plovdiv, Plovdiv 400, Bulgaria.

Research Institute at Medical University-Plovdiv, Plovdiv 4000, Bulgaria.

出版信息

Rev Neurosci. 2020 Jul 28;31(5):539-553. doi: 10.1515/revneuro-2019-0100.

DOI:10.1515/revneuro-2019-0100
PMID:32045356
Abstract

Neurodegenerative diseases comprise a large number of disorders with high impact on human health. Neurodegenerative processes are caused by various etiological factors and differ in their clinical presentation. Neuroinflammation is widely discussed as both a cause and a consequence in the manifestation of these disorders. The interplay between the two entities is considered as a major contributor to the ongoing disease progression. An attentive search and implementation of new and reliable markers specific for the processes of inflammation and degeneration is still needed. YKL-40 is a secreted glycoprotein produced by activated glial cells during neuroinflammation. Neuron-specific enolase (NSE), expressed mainly by neuronal cells, is a long-standing marker for neuronal damage. The aim of this review is to summarize, clarify, and evaluate the potential significance and relationship between YKL-40 and NSE as biomarkers in the monitoring and prognosis of a set of neurological diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. YKL-40 appears to be a more reliable biomarker in neurological diseases than NSE. The more prominent expression pattern of YKL-40 could be explained with the more obvious involvement of glial cells in pathological processes accompanying each neurodegenerative disease, whereas reduced NSE levels are likely related to low metabolic activity and increased death of neurons.

摘要

神经退行性疾病包括许多对人类健康有重大影响的疾病。神经退行性过程是由各种病因因素引起的,其临床表现也各不相同。神经炎症被广泛认为是这些疾病发生的原因和后果。这两个实体之间的相互作用被认为是疾病进展的主要原因。因此,仍需要积极寻找和应用新的、可靠的、针对炎症和退行性过程的标志物。YKL-40 是一种在神经炎症过程中由活化的神经胶质细胞产生的分泌型糖蛋白。神经元特异性烯醇化酶(NSE)主要由神经元细胞表达,是神经元损伤的长期标志物。本综述的目的是总结、阐明和评估 YKL-40 和 NSE 作为一组神经疾病(如阿尔茨海默病、帕金森病、亨廷顿病和多发性硬化症)的监测和预后的潜在意义和关系。YKL-40 似乎比 NSE 更能作为神经疾病的可靠生物标志物。YKL-40 更明显的表达模式可以用伴随每种神经退行性疾病的病理过程中神经胶质细胞更明显的参与来解释,而 NSE 水平降低可能与神经元代谢活性降低和死亡增加有关。

相似文献

1
YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation.YKL-40 和神经元特异性烯醇化酶在神经退行性变和神经炎症中的作用。
Rev Neurosci. 2020 Jul 28;31(5):539-553. doi: 10.1515/revneuro-2019-0100.
2
YKL-40 and the Cellular Metabolic Profile in Parkinson's Disease.YKL-40 与帕金森病的细胞代谢特征。
Int J Mol Sci. 2023 Nov 14;24(22):16297. doi: 10.3390/ijms242216297.
3
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.神经炎症生物标志物YKL-40在阿尔茨海默病及其他神经退行性疾病中的诊断功能
Expert Rev Proteomics. 2017 Apr;14(4):285-299. doi: 10.1080/14789450.2017.1304217. Epub 2017 Mar 20.
4
YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.YKL-40作为阿尔茨海默病治疗策略中的潜在生物标志物和可能靶点。
Curr Neuropharmacol. 2017;15(6):906-917. doi: 10.2174/1570159X15666170208124324.
5
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development.神经炎症生物标志物 YKL-40 与神经退行性疾病:研究进展。
Expert Rev Proteomics. 2019 Jul;16(7):593-600. doi: 10.1080/14789450.2019.1628643. Epub 2019 Jun 14.
6
Mitochondria at the interface between neurodegeneration and neuroinflammation.线粒体在神经变性和神经炎症之间的相互作用。
Semin Cell Dev Biol. 2020 Mar;99:163-171. doi: 10.1016/j.semcdb.2019.05.028. Epub 2019 Jun 5.
7
Early approaches of YKL-40 as a biomarker and therapeutic target for Parkinson's disease.YKL-40 作为帕金森病生物标志物和治疗靶点的早期研究进展。
Neurodegener Dis Manag. 2023 Apr;13(2):85-99. doi: 10.2217/nmt-2022-0010. Epub 2023 Jan 16.
8
Brain levels of neuron-specific and nonneuronal enolase in Huntington's disease.亨廷顿舞蹈病患者大脑中神经元特异性烯醇化酶和非神经元烯醇化酶的水平
J Neurochem. 1981 Nov;37(5):1338-40. doi: 10.1111/j.1471-4159.1981.tb04687.x.
9
Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.神经退行性疾病中的聚集病:机制与治疗意义
Neurodegener Dis. 2008;5(6):321-38. doi: 10.1159/000119459. Epub 2008 Feb 29.
10
New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.神经元特异性烯醇化酶在神经炎症、神经退行性变和神经保护中的作用新见解。
Brain Sci. 2018 Feb 18;8(2):33. doi: 10.3390/brainsci8020033.

引用本文的文献

1
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders.脑部疾病中的神经血管单元、神经炎症和神经退行性变标志物
Front Cell Neurosci. 2024 Oct 25;18:1491952. doi: 10.3389/fncel.2024.1491952. eCollection 2024.
2
Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism.探讨血清CD163、YKL40和VILIP-1水平与自闭症学龄前儿童自闭症严重程度及语言认知发展的关系。
Clin Psychopharmacol Neurosci. 2024 Aug 31;22(3):473-483. doi: 10.9758/cpn.23.1149. Epub 2024 Apr 24.
3
Serum levels of neurotensin, pannexin-1, and sestrin-2 and the correlations with sleep quality or/and cognitive function in the patients with chronic insomnia disorder.
慢性失眠障碍患者血清中神经降压素、泛连接蛋白-1和 sestrin-2 的水平及其与睡眠质量或/和认知功能的相关性。
Front Psychiatry. 2024 May 13;15:1360305. doi: 10.3389/fpsyt.2024.1360305. eCollection 2024.
4
Recently Updated Role of Chitinase 3-like 1 on Various Cell Types as a Major Influencer of Chronic Inflammation.最近,几类细胞中几丁质酶 3 样蛋白 1 作为慢性炎症主要影响因子的作用。
Cells. 2024 Apr 14;13(8):678. doi: 10.3390/cells13080678.
5
Psychological Stress Analysis to Evaluate the Effects of Transcranial Magnetic Stimulation on Mood Regulation and Quality of Life in Patients with Bipolar Disorder.心理压力分析评估经颅磁刺激对双相情感障碍患者情绪调节和生活质量的影响。
Actas Esp Psiquiatr. 2024 Apr;52(2):130-137. doi: 10.62641/aep.v52i2.1555.
6
Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases.几丁质酶 3 样蛋白 1 在巨噬细胞极化及疾病发生发展中的潜在作用和未来展望。
Int J Mol Sci. 2023 Nov 9;24(22):16149. doi: 10.3390/ijms242216149.
7
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review.阿尔茨海默病和多发性硬化症疾病进展的脑脊液炎症生物标志物:系统评价。
Front Immunol. 2023 Jul 13;14:1162340. doi: 10.3389/fimmu.2023.1162340. eCollection 2023.
8
Chitinase Signature in the Plasticity of Neurodegenerative Diseases.神经退行性疾病可塑性中的几丁质酶特征。
Int J Mol Sci. 2023 Mar 27;24(7):6301. doi: 10.3390/ijms24076301.
9
Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者血清YKL-40水平与脑白质高信号
J Inflamm Res. 2023 Jan 25;16:311-319. doi: 10.2147/JIR.S398701. eCollection 2023.
10
Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer.YKL-40 的上调促进结直肠癌患者的转移表型,并与不良预后和治疗反应相关。
Cells. 2022 Nov 11;11(22):3568. doi: 10.3390/cells11223568.